- Correction
- Open access
- Published:
Correction to: RETRACTED ARTICLE: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2
Journal of Experimental & Clinical Cancer Research volume 40, Article number: 204 (2021)
The Original Article was published on 21 February 2019
Correction to: J Exp Clin Cancer Res 38, 94 (2019)
https://doi.org/10.1186/s13046-019-1100-8
Following publication of the original article [1], the authors identified some minor errors in image typesetting in Fig. 6; specifically the flow cytometry apoptosis experiment detailed in Fig. 6a.
The corrected figure is given below. The correction does not have any effect on the results or conclusions of the paper. The original article has been updated.
Overexpressed LINC00968 or silenced WNT2 contributes to promoted apoptosis of breast cancer cells. a the apoptosis of MCF-7 cells after transduction in each group as analyzed by flow cytometry. b the cell apoptosis rate in each group. c protein bands of Bax, cleaved-PARP, cleaved-caspase3 and Bcl-2 in MCF-7/ADM cells after transduction in each group as measured by Western blot analysis. d the protein levels of Bax, cleaved-PARP, cleaved-caspase3 and Bcl-2 in each group. *p < 0.05 vs. the control group; #p < 0.05 vs. the blank and NC groups; &p < 0.05 vs. the LINC00968 vector + WNT2 vector group
Reference
Xiu DH, Liu GF, Yu SN, Li LY, Zhao GQ, Liu L, et al. Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2. J Exp Clin Cancer Res. 2019;38:94 https://doi.org/10.1186/s13046-019-1100-8.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1186/s13046-021-02121-3
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Xiu, DH., Liu, GF., Yu, SN. et al. Correction to: RETRACTED ARTICLE: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2. J Exp Clin Cancer Res 40, 204 (2021). https://doi.org/10.1186/s13046-021-01991-x
Published:
DOI: https://doi.org/10.1186/s13046-021-01991-x